Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander A Vinks

Showing results (171-180 of 196) with videos related to

Pageof 20
Sort By:
Clinical Pharmacology and Therapeutics|December 23, 2020
Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's DiseaseYe Xiong, Tomoyuki Mizuno, Ruben Colman, et al.
British Journal of Clinical Pharmacology|April 13, 2025
The feasibility of pharmacokinetic-based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trialAlexandra Power-Hays, Ruth Namazzi, Min Dong, et al.
Annals of Neurology|November 17, 2020
A Pilot Randomized, Controlled, Double-Blind Trial of Bumetanide to Treat Neonatal SeizuresJanet S Soul, Ann M Bergin, Christian Stopp, et al.
Clinical Pharmacology and Therapeutics|May 11, 2026
Clinical Model-Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric PatientsZachary L Taylor, Takanobu Nadai, Kei Irie, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2021
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's diseaseRuben J Colman, Ye Xiong, Tomoyuki Mizuno, et al.
Clinical Transplantation|July 24, 2025
Belatacept Pharmacokinetic Analysis of Belatacept Early Steroid Withdrawal Trial (BEST) to Clinical Outcomes and Compared With Reported BENEFIT and BENEFIT-EXT Pharmacokinetic AnalysisAlexandra Pyatt, Melissa McGowan, Ryota Tanaka, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2015
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell TransplantationSonata Jodele, Tsuyoshi Fukuda, Kana Mizuno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2014
A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium ReportMaryam Fouladi, John P Perentesis, Lars M Wagner, et al.
Molecular Genetics and Metabolism|September 16, 2018
Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disordersSusan A Berry, Jerry Vockley, Alexander A Vinks, et al.
The Lancet. Infectious Diseases|April 29, 2014
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutionsJason A Roberts, Mohd H Abdul-Aziz, Jeffrey Lipman, et al.
Pageof 20

Showing results (171-180 of 196) with videos related to

Sort By:
Pageof 20
Clinical Pharmacology and Therapeutics|December 23, 2020
Real-World Infliximab Pharmacokinetic Study Informs an Electronic Health Record-Embedded Dashboard to Guide Precision Dosing in Children with Crohn's DiseaseYe Xiong, Tomoyuki Mizuno, Ruben Colman, et al.
British Journal of Clinical Pharmacology|April 13, 2025
The feasibility of pharmacokinetic-based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trialAlexandra Power-Hays, Ruth Namazzi, Min Dong, et al.
Annals of Neurology|November 17, 2020
A Pilot Randomized, Controlled, Double-Blind Trial of Bumetanide to Treat Neonatal SeizuresJanet S Soul, Ann M Bergin, Christian Stopp, et al.
Clinical Pharmacology and Therapeutics|May 11, 2026
Clinical Model-Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric PatientsZachary L Taylor, Takanobu Nadai, Kei Irie, et al.
Alimentary Pharmacology & Therapeutics|December 22, 2021
Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's diseaseRuben J Colman, Ye Xiong, Tomoyuki Mizuno, et al.
Clinical Transplantation|July 24, 2025
Belatacept Pharmacokinetic Analysis of Belatacept Early Steroid Withdrawal Trial (BEST) to Clinical Outcomes and Compared With Reported BENEFIT and BENEFIT-EXT Pharmacokinetic AnalysisAlexandra Pyatt, Melissa McGowan, Ryota Tanaka, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 13, 2015
Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell TransplantationSonata Jodele, Tsuyoshi Fukuda, Kana Mizuno, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2014
A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium ReportMaryam Fouladi, John P Perentesis, Lars M Wagner, et al.
Molecular Genetics and Metabolism|September 16, 2018
Pharmacokinetics of glycerol phenylbutyrate in pediatric patients 2 months to 2 years of age with urea cycle disordersSusan A Berry, Jerry Vockley, Alexander A Vinks, et al.
The Lancet. Infectious Diseases|April 29, 2014
Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutionsJason A Roberts, Mohd H Abdul-Aziz, Jeffrey Lipman, et al.
Pageof 20